AI & Research Partnerships: Kazakhstan and KU Leuven-linked partners will use AI to model metallurgical processes, predict new materials, and optimize critical-raw-material supply chains, aiming to speed lab-to-industry translation. Health & Pharma: Takeda says its oral zasocitinib beat deucravacitinib in a Phase 3 plaque psoriasis study, with over 35% hitting complete skin clearance at week 16. Biotech Race: A new survey finds China rapidly closing the gap with the US in biotech, especially in manufacturing and clinical development, while the US still leads in frontier research-to-market. Precision Oncology: Alps Group is launching a patient-derived organoid program for personalized cancer treatment and preclinical drug screening, targeting a defined regulatory path in Malaysia. Cybersecurity for AI: Checkmarx adds “AI Inventory” to track AI models, agents, and MCP servers in production and generate an AI bill of materials for governance. Digital Health Data: Enoda rolls out a real-world mobility data platform for pharma and clinical trials, aiming to better measure everyday impacts of therapies. Medical Devices: Solenic Medical gets FDA IDE approval to start a pivotal trial of its non-invasive SOLA-2 system for periprosthetic joint infections. Space & Industry: India’s space program continues shifting from science missions to strategic national capability, with growing private-sector involvement.